803.90
-3.80
(-0.47%)
At close: January 10 at 3:29:28 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
646,811.00
632,172.00
392,619.00
761,319.00
692,695.00
Investing Cash Flow
-656,833.00
-573,416.00
-366,426.00
-780,802.00
-642,273.00
Financing Cash Flow
-40,698.00
-51,804.00
-45,013.00
-25,561.00
-57,453.00
End Cash Position
101,349.00
57,472.00
50,520.00
69,340.00
114,383.00
Capital Expenditure
-393,900.00
-396,130.00
-142,820.00
-455,252.00
-87,503.00
Issuance of Debt
652,200.00
200,000.00
193,574.00
20,000.00
--
Repayment of Debt
-648,004.00
-209,019.00
-195,018.00
-5,197.00
-45,543.00
Free Cash Flow
252,911.00
236,042.00
249,799.00
306,067.00
605,192.00
3/31/2021 - 12/17/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HESTERBIO.NS Hester Biosciences Limited
2,264.20
-3.48%
MOREPENLAB.BO Morepen Laboratories Limited
68.22
-3.75%
AMRUTANJAN.NS Amrutanjan Health Care Limited
702.45
-1.11%
UNICHEMLAB.NS Unichem Laboratories Limited
692.65
-1.14%
APLLTD.NS Alembic Pharmaceuticals Limited
1,010.05
-4.24%
SUVENPHAR.NS Suven Pharmaceuticals Limited
1,061.95
-3.81%
SPARC.NS Sun Pharma Advanced Research Company Limited
183.52
-3.13%
TORNTPHARM.NS Torrent Pharmaceuticals Limited
3,274.45
-1.42%
BLISSGVS.NS Bliss GVS Pharma Limited
160.47
-3.88%
SOLARA.NS Solara Active Pharma Sciences Limited
654.70
-4.07%